Shelley Horner elected as IPASA Vice President

Shelley Horner, Novartis South Africa Country President, has been elected as the Vice President of the Innovative Pharmaceutical Association of South Africa (IPASA).

With more than 30 years’ professional experience in the pharmaceutical sector, her passion and expertise lie in oncology, which led her to become the Novartis Head of Oncology for South AFrica in October 2015.

Horner has been an executive member of IPASA since January 2020 and her valuable contribution to the association is the basis of her well-deserved appointment to the role of Vice President. “As a female role model in business I hope to champion the development of more women in senior roles and to ensure we have a seat at the table and are part of the discussion and debate in business.

“IPASA’s role in the industry is critical, as it represents the collective voice of many multinationals in the healthcare sector. As global advances are made in innovative treatments, it is important that patients can access these, especially as many newer treatments address the root causes of debilitating diseases,” she adds.

Her illustrious career stands her in good stead to help lead the association forward in achieving its mandate for 2022.

“With the most recent advances in healthcare, we must work towards equal access for all patients. I look forward to working closely with the member company CEO’s and working groups in IPASA as we strive towards a common goal of ensuring access to innovative treatment and being involved in ongoing discussions with the government and other external stakeholders regarding healthcare in our country.”

Shelley lives by these wise words: “I never lose, I either win or learn” . Nelson Mandela